Ensign Peak Advisors, Inc Syneos Health, Inc. Transaction History

Ensign Peak Advisors, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$33.32 - $40.98 $21,658 - $26,636	650 Added 2.36%	28,143 $1 Million
Q4 2022 Feb 13, 2023	SELL	$25.32 - $51.45 $125,334 - $254,677	-4,950 Reduced 15.26%	27,493 $1.01 Million
Q3 2022 Nov 14, 2022	SELL	$46.5 - $79.14 $274,350 - $466,926	-5,900 Reduced 15.39%	32,443 $1.53 Million
Q4 2021 Feb 11, 2022	SELL	$86.01 - $102.89 $3.2 Million - $3.83 Million	-37,250 Reduced 49.28%	38,343 $3.94 Million
Q3 2021 Nov 12, 2021	BUY	$84.7 - $96.31 $415,030 - $471,919	4,900 Added 6.93%	75,593 $6.61 Million
Q2 2021 Aug 13, 2021	BUY	$76.44 - $89.57 $1.55 Million - $1.82 Million	20,300 Added 40.28%	70,693 $6.33 Million
Q1 2021 May 12, 2021	SELL	$67.36 - $80.76 $57,256 - $68,646	-850 Reduced 1.66%	50,393 $3.82 Million
Q4 2020 Feb 12, 2021	BUY	$53.08 - $69.86 $45,118 - $59,381	850 Added 1.69%	51,243 $3.49 Million
Q1 2020 May 11, 2020	SELL	$32.64 - $73.63 $273,033 - $615,914	-8,365 Reduced 14.24%	50,393 $1.99 Million
Q4 2019 Feb 14, 2020	BUY	$48.0 - $59.55 $2.82 Million - $3.5 Million	58,758 New	58,758 $3.5 Million

731K

Ticker SYNH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,653,000
Description
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.